GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iZafe Group AB (OSTO:IZAFE B) » Definitions » EV-to-Revenue

iZafe Group AB (OSTO:IZAFE B) EV-to-Revenue : 10.59 (As of Jun. 01, 2025)


View and export this data going back to 2011. Start your Free Trial

What is iZafe Group AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, iZafe Group AB's enterprise value is kr84.23 Mil. iZafe Group AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was kr7.95 Mil. Therefore, iZafe Group AB's EV-to-Revenue for today is 10.59.

The historical rank and industry rank for iZafe Group AB's EV-to-Revenue or its related term are showing as below:

OSTO:IZAFE B' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.51   Med: 29.4   Max: 1074.69
Current: 10.59

During the past 13 years, the highest EV-to-Revenue of iZafe Group AB was 1074.69. The lowest was 3.51. And the median was 29.40.

OSTO:IZAFE B's EV-to-Revenue is ranked worse than
84.1% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3.09 vs OSTO:IZAFE B: 10.59

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-01), iZafe Group AB's stock price is kr0.248. iZafe Group AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.03. Therefore, iZafe Group AB's PS Ratio for today is 8.00.


iZafe Group AB EV-to-Revenue Historical Data

The historical data trend for iZafe Group AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iZafe Group AB EV-to-Revenue Chart

iZafe Group AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.76 98.63 64.54 37.79 7.97

iZafe Group AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.79 11.48 14.14 9.84 7.97

Competitive Comparison of iZafe Group AB's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, iZafe Group AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iZafe Group AB's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where iZafe Group AB's EV-to-Revenue falls into.


;
;

iZafe Group AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

iZafe Group AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=84.225/7.954
=10.59

iZafe Group AB's current Enterprise Value is kr84.23 Mil.
iZafe Group AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr7.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iZafe Group AB  (OSTO:IZAFE B) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

iZafe Group AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.248/0.031
=8.00

iZafe Group AB's share price for today is kr0.248.
iZafe Group AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iZafe Group AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of iZafe Group AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


iZafe Group AB Business Description

Traded in Other Exchanges
Address
David Bagares Gata 3, Stockholm, SWE, 111 38
iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

iZafe Group AB Headlines

No Headlines